VenBio Partners has led a €36m series-B round for NorthSea Therapeutics (NST), a Netherlands-based biotech company developing drugs against metabolic, inflammatory and fibrotic diseases.
GP and Katalist's founders are planning bolt-ons for the food and pharma supply chain software firm
Italian sports technology provider first sale attempt was hampered by the onset of COVID-19 in early 2020
Nick Chronias will lead the firm’s focus on private credit and private infrastructure secondaries
Dörte Höppner joined the GP in 2017 and will be responsible for its ESG initiatives globally